Over 375 industry leaders from 55+ Pharma & Biotech companies registered for our webinar “Leveraging Patient Data and AI for Life Science Product Launches”. The list included Abbott, Amgen, AstraZeneca, BioMarin Pharmaceutical Inc., Bristol Myers Squibb, Biogen, Eli Lilly and Company, Genentech, Gilead Sciences, Jazz Pharmaceuticals, Kyowa Kirin, Inc.- U.S., Reata Pharmaceuticals, Inc., The Janssen Pharmaceutical Companies of Johnson & Johnson, Merck, Merck Group, Moderna, Novartis, PTC Therapeutics, Inc., Regeneron, Takeda, Takeda Oncology, Sanofi, UCB, Pfizer and many others.

In this webinar, we covered the role of Integrated Patient Data™ and Medically Smart AI™ in supporting pharmaceutical and biotechnology companies. Lisa Griffith and Patricia Dorling from Chiesi USA, Inc. USA joined Inder Jaggi from Clinakos Inc. and Wes Michael from Rare Patient Voice to lead a deep discussion about how patient data and AI can play a pivotal role within Commercial, Medical Affairs, HEOR and RWE for new product launches. A real world Case Study on Fabry Disease provided some real world perspectives on how these technologies can significantly enhance not only new product launches but also provide value for other pre- and post-marketing activities.

Contact us directly if you were not able to attend and need a link to the recording